Cetera Investment Advisers decreased its position in Vital Farms, Inc. (NASDAQ:VITL - Free Report) by 36.1% in the 4th quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 55,795 shares of the company's stock after selling 31,508 shares during the quarter. Cetera Investment Advisers owned about 0.13% of Vital Farms worth $2,103,000 as of its most recent filing with the SEC.
Several other large investors have also made changes to their positions in VITL. CIBC Private Wealth Group LLC grew its stake in shares of Vital Farms by 152.1% in the 4th quarter. CIBC Private Wealth Group LLC now owns 895 shares of the company's stock valued at $35,000 after buying an additional 540 shares in the last quarter. US Bancorp DE grew its stake in shares of Vital Farms by 160.3% in the 4th quarter. US Bancorp DE now owns 1,416 shares of the company's stock valued at $53,000 after buying an additional 872 shares in the last quarter. Frazier Financial Advisors LLC bought a new stake in shares of Vital Farms in the 4th quarter valued at approximately $59,000. Principal Securities Inc. lifted its holdings in Vital Farms by 29.4% in the 4th quarter. Principal Securities Inc. now owns 1,673 shares of the company's stock worth $63,000 after purchasing an additional 380 shares during the last quarter. Finally, Rothschild Investment LLC lifted its holdings in Vital Farms by 191.2% in the 4th quarter. Rothschild Investment LLC now owns 1,814 shares of the company's stock worth $68,000 after purchasing an additional 1,191 shares during the last quarter. Institutional investors own 98.59% of the company's stock.
Insider Buying and Selling at Vital Farms
In other news, CEO Russell Diez-Canseco sold 45,124 shares of the company's stock in a transaction on Monday, April 14th. The stock was sold at an average price of $33.69, for a total transaction of $1,520,227.56. Following the transaction, the chief executive officer now owns 703,736 shares of the company's stock, valued at $23,708,865.84. This represents a 6.03% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available through this link. Also, insider Matthew Ohayer sold 4,000 shares of the company's stock in a transaction on Monday, March 24th. The shares were sold at an average price of $31.39, for a total value of $125,560.00. Following the transaction, the insider now directly owns 6,966,890 shares in the company, valued at $218,690,677.10. This trade represents a 0.06% decrease in their position. The disclosure for this sale can be found here. Insiders have sold 93,124 shares of company stock worth $3,019,308 over the last three months. Company insiders own 27.60% of the company's stock.
Vital Farms Stock Performance
Shares of VITL stock traded down $1.11 during trading hours on Friday, reaching $33.23. 715,928 shares of the company's stock were exchanged, compared to its average volume of 1,028,769. Vital Farms, Inc. has a fifty-two week low of $27.91 and a fifty-two week high of $48.41. The stock has a market capitalization of $1.48 billion, a P/E ratio of 29.67 and a beta of 0.94. The business has a fifty day moving average price of $33.17 and a 200-day moving average price of $34.99. The company has a quick ratio of 2.81, a current ratio of 3.24 and a debt-to-equity ratio of 0.04.
Vital Farms (NASDAQ:VITL - Get Free Report) last issued its earnings results on Thursday, May 8th. The company reported $0.37 EPS for the quarter, beating analysts' consensus estimates of $0.26 by $0.11. Vital Farms had a return on equity of 22.29% and a net margin of 8.68%. The business had revenue of $162.19 million during the quarter, compared to analyst estimates of $164.43 million. During the same period in the prior year, the company posted $0.43 earnings per share. Vital Farms's revenue was up 9.7% on a year-over-year basis. Analysts predict that Vital Farms, Inc. will post 1.11 EPS for the current fiscal year.
Analyst Upgrades and Downgrades
VITL has been the subject of several analyst reports. Stifel Nicolaus upgraded Vital Farms from a "hold" rating to a "buy" rating and set a $44.00 target price for the company in a report on Friday, February 28th. Telsey Advisory Group restated an "outperform" rating and issued a $52.00 target price on shares of Vital Farms in a report on Monday, May 5th. Morgan Stanley reduced their target price on Vital Farms from $40.00 to $39.00 and set an "overweight" rating for the company in a report on Thursday, April 17th. BMO Capital Markets upgraded Vital Farms to a "strong-buy" rating in a report on Tuesday, May 6th. Finally, DA Davidson reduced their target price on Vital Farms from $44.00 to $42.00 and set a "buy" rating for the company in a report on Friday, March 14th. Eight equities research analysts have rated the stock with a buy rating and one has issued a strong buy rating to the company. According to MarketBeat, Vital Farms presently has an average rating of "Buy" and an average price target of $44.63.
Get Our Latest Analysis on VITL
Vital Farms Company Profile
(
Free Report)
Vital Farms, Inc, a food company, provides pasture-raised products in the United States. It offers shell eggs, butter, hard-boiled eggs, and liquid whole eggs. The company was founded in 2007 and is headquartered in Austin, Texas.
Read More

Before you consider Vital Farms, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Vital Farms wasn't on the list.
While Vital Farms currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2025. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.